TFO
BLCM

Tarbox Family Office’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Tarbox Family Office’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-300
Closed -$1K – 1199
2021
Q3 		$1K Hold
300
– – ﹤0.01% 1142
2021
Q2 		$1K Buy
+300
New +$963 ﹤0.01% 1121

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tarbox Family Office's BLCM Position: Q4 2021 in Review

Tarbox Family Office sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2021, closing a stake of 300 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in BLCM in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 24 funds tracked by Wall St. Rank hold BLCM as of Q4 2021.

  • Tarbox Family Office reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Tarbox Family Office sold 300 Bellicum Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1K.
  • Tarbox Family Office first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
  • Tarbox Family Office's Bellicum Pharmaceuticals, Inc. position peaked at $1K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2021.

Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.